title: Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers.
abstract: Polymeric and biodegradable nanoparticles are frequently used in drug delivery systems. In this study silk fibroin-albumin blended nanoparticles were prepared using the desolvation method without any surfactant. These nanoparticles are easily internalized by the cells, reside within perinuclear spaces and act as carriers for delivery of the model drug methotrexate. Methotrexate loaded nanoparticles have better encapsulation efficiency, drug loading ability and less toxicity. The in vitro release behavior of methotrexate from the nanoparticles suggests that about 85% of the drug gets released after 12 days. The encapsulation and loading of a drug would depend on factors such as size, charge and hydrophobicity, which affect drug release. MTT assay and conjugation of particles with FITC demonstrate that the silk fibroin-albumin nanoparticles do not affect the viability and biocompatibility of cells. This blended nanoparticle, therefore, could be a promising nanocarrier for the delivery of drugs and other bioactive molecules.
authors.affiliation: Department of Biotechnology, Indian Institute of Technology, Kharagpur-721302, India.
authors.forename: B
authors.initials: B
authors.lastname: Subia
authors.forename: S C
authors.initials: SC
authors.lastname: Kundu
mesh_terms: D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000494:pharmacology; D012831:Bombyx / Q000737:chemistry; D001943:Breast Neoplasms / Q000188:drug therapy; D002460:Cell Line; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D004337:Drug Carriers / Q000737:chemistry*; D005260:Female; D005349:Fibroins / Q000737:chemistry* / Q000633:toxicity; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage* / Q000494:pharmacology; D053758:Nanoparticles / Q000737:chemistry* / Q000633:toxicity / Q000648:ultrastructure; D010316:Particle Size; D012709:Serum Albumin / Q000737:chemistry* / Q000633:toxicity; D017550:Spectroscopy, Fourier Transform Infrared
chemical_list: D000964:Antimetabolites, Antineoplastic; D004337:Drug Carriers; D012709:Serum Albumin; D005349:Fibroins; D008727:Methotrexate